New advances in the chronic lymphocytic leukaemia genome

The Chronic Lymphatic Leukemia (CLL) Genome Consortium moves closer to the functional study of the genome and its application for improving the treatment of the disease. Researchers can now identify functional differences in leukemia cells. Their findings provide a new classification of the disease that could, eventually, improve predictions of the best time for starting treatment.